HKSH News

    Improving the Standard of Care for frontline MCL patients: Current Success and Future Directions

    Improving the Standard of Care for frontline MCL patients: Current Success and Future Directions

    Date: 24 Nov 2025 (Mon)

    Venue: Salon II-III, Hyatt Regency, Tsim Sha Tsui

    Time: 7:15 – 8:30 pm

    7:15 – 7:20   Welcome & Introduction

    7:20 – 8:15    Lecture

    8:15 – 8:30    Q&A

    8:30 onwards         Dinner

    Speaker: Univ.-Prof. Dr. med Georg Hess  

    Professor of Medicine, Head of Study Department Hematology and Oncology, University Medical School, Johannes Gutenberg-University Mainz

    Chairperson: Dr. Vivien Wai Man Mak, Specialist in Haematology and Haematological Oncology

    Learning objectives: After participating in the symposium, attendees should be able to:

    • Understand and discuss the latest evidence regarding the management of frontline MCL patients
    • Analyse how the updated evidence influences current clinical practice, including the roles of BTKi and role of autologous stem cell transplantation
    • Discuss the additional unmet needs in MCL treatment and directions for future studies

    CME Accreditation: Hong Kong College of Paediatricians, Pathologists, Physicians, and Radiologists

    Registration